| Literature DB >> 34607293 |
Jason C Mixdorf1, Dhanabalan Murali2, Yangchun Xin2, Alexandra H DiFilippo3, Eduardo Aluicio-Sarduy4, Todd E Barnhart4, Jonathan W Engle5, Paul A Ellison4, Bradley T Christian3.
Abstract
[11C]ER176 is a next generation PET radioligand for imaging 18 kDa translocator protein, a biomarker for neuroinflammation. The goal of this work was to investigate alternative strategies for the radiochemical synthesis, purification, and formulation of [11C]ER176. An optimized tri-solvent high-performance liquid chromatography (HPLC) protocol is described to separate the hydro-de-chlorinated byproduct from [11C]ER176. A newly implemented solid phase extraction work-up efficiently removed HPLC solvent while maintaining chemical purity and overall radiochemical yield and purity. This new HPLC purification and final formulation was completed within 40 min, providing 2.7 ± 0.5 GBq of [11C]ER176 at end of synthesis with 1400 ± 300 GBq/μmol molar activity while meeting all specifications for radiopharmaceutical quality control tests for human research use.Entities:
Keywords: 11-Carbon; ER176; Neuroinflammation; PET; Radiochemistry; TSPO
Mesh:
Substances:
Year: 2021 PMID: 34607293 PMCID: PMC9191690 DOI: 10.1016/j.apradiso.2021.109954
Source DB: PubMed Journal: Appl Radiat Isot ISSN: 0969-8043 Impact factor: 1.787